Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center - Heart and Vascular Research
mi
from
Seattle, WA
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center - Heart and Vascular Research
mi
from
Seattle, WA
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Medical Center
mi
from
Miami, FL
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Kaiser Foundation Hospital
mi
from
Honolulu, HI
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Kaiser Foundation Hospital
mi
from
Honolulu, HI
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Covenant Medical Center
mi
from
Saginaw, MI
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Covenant Medical Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
University at Buffalo Endovascular/Vascular Surgery
mi
from
Buffalo, NY
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
University at Buffalo Endovascular/Vascular Surgery
mi
from
Buffalo, NY
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Providence Heart Clinic
mi
from
Portland, OR
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Providence Heart Clinic
mi
from
Portland, OR
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
North Carolina Heart and Vascular
mi
from
Raleigh, NC
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
North Carolina Heart and Vascular
mi
from
Raleigh, NC
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Klinikum Rosenheim
mi
from
Rosenheim,
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Klinikum Rosenheim
mi
from
Rosenheim,
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
St. Luke's Medical Center
mi
from
Phoenix, AZ
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
St. Luke's Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Midwest Aortic and Vascular Institute (MAVI)
mi
from
North Kansas City, MO
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Midwest Aortic and Vascular Institute (MAVI)
mi
from
North Kansas City, MO
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Sanford Health
mi
from
Fargo, ND
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Sanford Health
mi
from
Fargo, ND
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Texas Health Research - Presbyterian Heart and Vascular
mi
from
Dallas, TX
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Texas Health Research - Presbyterian Heart and Vascular
mi
from
Dallas, TX
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Texas Health Research - Presbyterian Hospital of Plano
mi
from
Plano, TX
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Texas Health Research - Presbyterian Hospital of Plano
mi
from
Plano, TX
Click here to add this to my saved trials
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated:  12/31/1969
Charleston Area Medical Center
mi
from
Charleston, WV
In-Stent Restenosis Post-Approval Study
Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)
Status: Enrolling
Updated: 12/31/1969
Charleston Area Medical Center
mi
from
Charleston, WV
Click here to add this to my saved trials
Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms
Prospective, Multi-Center, Single-Arm Study of Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils in Wide-Neck, Intracranial, Bifurcating Aneurysms of Middle Cerebral and Basilar Arteries
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center Jacksonville
mi
from
Jacksonville, FL
Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms
Prospective, Multi-Center, Single-Arm Study of Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils in Wide-Neck, Intracranial, Bifurcating Aneurysms of Middle Cerebral and Basilar Arteries
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms
Prospective, Multi-Center, Single-Arm Study of Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils in Wide-Neck, Intracranial, Bifurcating Aneurysms of Middle Cerebral and Basilar Arteries
Status: Enrolling
Updated:  12/31/1969
Baptist Hospital of Miami, BCVI
mi
from
Miami, FL
Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms
Prospective, Multi-Center, Single-Arm Study of Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils in Wide-Neck, Intracranial, Bifurcating Aneurysms of Middle Cerebral and Basilar Arteries
Status: Enrolling
Updated: 12/31/1969
Baptist Hospital of Miami, BCVI
mi
from
Miami, FL
Click here to add this to my saved trials
Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms
Prospective, Multi-Center, Single-Arm Study of Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils in Wide-Neck, Intracranial, Bifurcating Aneurysms of Middle Cerebral and Basilar Arteries
Status: Enrolling
Updated:  12/31/1969
Tallahassee Neurological Clinic
mi
from
Tallahassee, FL
Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms
Prospective, Multi-Center, Single-Arm Study of Reverse Medical Barrel™ Vascular Reconstruction Device for Adjunctive Treatment to Embolic Coils in Wide-Neck, Intracranial, Bifurcating Aneurysms of Middle Cerebral and Basilar Arteries
Status: Enrolling
Updated: 12/31/1969
Tallahassee Neurological Clinic
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions
Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Colorado
mi
from
Denver, CO
Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions
Cardiac Remodeling and Circulating Biomarkers in Pediatric Left Ventricular Pressure Loading Lesions
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System
Evaluation of the Technical Success of Intravascular Ultrasound (IVUS) Guided Vena Cava Filter (VCF) Placement Using the LUMIFI™ With Crux® VCF System (LUMIFI Clinical Study)
Status: Enrolling
Updated:  12/31/1969
Surgical Care Associates
mi
from
Louisville, KY
Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System
Evaluation of the Technical Success of Intravascular Ultrasound (IVUS) Guided Vena Cava Filter (VCF) Placement Using the LUMIFI™ With Crux® VCF System (LUMIFI Clinical Study)
Status: Enrolling
Updated: 12/31/1969
Surgical Care Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System
Evaluation of the Technical Success of Intravascular Ultrasound (IVUS) Guided Vena Cava Filter (VCF) Placement Using the LUMIFI™ With Crux® VCF System (LUMIFI Clinical Study)
Status: Enrolling
Updated:  12/31/1969
Vascular Access Solutions
mi
from
Orangeburg, SC
Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF System
Evaluation of the Technical Success of Intravascular Ultrasound (IVUS) Guided Vena Cava Filter (VCF) Placement Using the LUMIFI™ With Crux® VCF System (LUMIFI Clinical Study)
Status: Enrolling
Updated: 12/31/1969
Vascular Access Solutions
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital
mi
from
La Jolla, CA
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
mi
from
Roslyn, NY
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Sanford Medical Center
mi
from
Fargo, ND
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Sanford Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
University Hospitals Elyria Medical Center
mi
from
Elyria, OH
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
University Hospitals Elyria Medical Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
AnMed Health Medical Center
mi
from
Anderson, SC
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
AnMed Health Medical Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
East Texas Medical Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Lankenau Medical Center
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated:  12/31/1969
Barnes Jewish University
mi
from
Saint Louis, MO
Medtronic Resolute Onyx 2.0 mm Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study
Status: Enrolling
Updated: 12/31/1969
Barnes Jewish University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Scripps Green Hospital
mi
from
La Jolla, CA
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Scripps Green Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Morton Plant Hospital
mi
from
Clearwater, FL
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Saint John's Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Saint Francis Hospital
mi
from
Roslyn, NY
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Saint Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Sanford Medical Center
mi
from
Fargo, ND
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Sanford Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
University Hospitals Elyria Medical Center
mi
from
Elyria, OH
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
University Hospitals Elyria Medical Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
AnMed Health Medical Center
mi
from
Anderson, SC
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
AnMed Health Medical Center
mi
from
Anderson, SC
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated:  12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
Status: Enrolling
Updated: 12/31/1969
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials